(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Horizon Therapeutics, Xenetic Biosciences, and iFresh.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Horizon Therapeutics (HZNP) 108.92 9.18% 2021-08-04 07:08:54
2 Xenetic Biosciences (XBIO) 3.80 7.95% 2021-08-04 07:12:47
3 iFresh (IFMK) 1.30 6.56% 2021-08-04 07:11:46
4 Upland Software (UPLD) 36.10 3.08% 2021-08-04 07:10:39
5 TherapeuticsMD (TXMD) 1.01 3.06% 2021-08-04 07:12:38
6 Caesars Entertainment (CZR) 88.99 2.55% 2021-08-04 07:07:54
7 DouYu (DOYU) 3.84 2.4% 2021-08-04 07:11:32
8 XP (XP) 43.16 2.03% 2021-08-04 07:12:50
9 AmerisourceBergen (ABC) 126.15 1.97% 2021-08-04 07:12:57
10 Empirical Financial Services, LLC d/b/a Empirical Wealth Management (ABC) 126.15 1.97% 2021-08-04 07:12:57

The three most active and biggest losers today are Akamai Technologies, AMC, and ImmunoGen.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Akamai Technologies (AKAM) 112.76 -5.89% 2021-08-04 07:07:15
2 AMC (AMC) 32.38 -3.6% 2021-08-04 07:13:09
3 ImmunoGen (IMGN) 5.45 -3.54% 2021-08-04 07:09:01
4 Match Group (MTCH) 152.88 -3.53% 2021-08-04 07:11:59
5 American Tower (AMT) 275.25 -3.2% 2021-08-04 07:13:12
6 Vulcan Materials Company (VMC) 176.00 -2.68% 2021-08-04 07:16:39
7 Exact Sciences (EXAS) 101.65 -2.46% 2021-08-04 07:08:11
8 ZoomInfo (ZI) 55.25 -2.21% 2021-08-04 07:12:52
9 Arcturus Therapeutics (ARCT) 57.08 -2.01% 2021-08-04 07:11:04
10 Diamondback Energy (FANG) 79.00 -1.9% 2021-08-04 07:08:14

Most Active Premarket Winners today

1. Horizon Therapeutics (HZNP) – Premarket: 9.18%

NASDAQ Composite ended the session with Horizon Therapeutics sliding 0.02% to $99.76 on Wednesday while NASDAQ Composite rose 0.55% to $14,761.30.

Volume

Today’s last reported volume for Horizon Therapeutics is 1918850, 23.82% above its average volume of 1549690.

Horizon Therapeutics’s last close was $100.02, 4.62% below its 52-week high of $104.86.

Horizon Therapeutics’s Sales

Horizon Therapeutics’s sales growth is 48% for the current quarter and 72.5% for the next. The company’s growth estimates for the current quarter is 120% and a drop 16.7% for the next.

Horizon Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 2.19B for the twelve trailing months.

Volatility

Horizon Therapeutics’s last week, last month’s, and last quarter’s current volatility was 0.60%, 0.40%, and 1.42%, respectively.

Horizon Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.32% (last week), 1.50% (last month), and 1.42% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Horizon Therapeutics’s stock is considered to be overbought (>=80).

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $99.76 at 08:34 EST, under its 52-week high of $104.86 and way higher than its 52-week low of $60.82.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s worth is higher than its 50-day moving average of $95.60 and way higher than its 200-day moving average of $90.33.

More news about Horizon Therapeutics.

2. Xenetic Biosciences (XBIO) – Premarket: 7.95%

NASDAQ Composite ended the session with Xenetic Biosciences falling 21.08% to $3.52 on Wednesday, following the last session’s downward trend. NASDAQ Composite jumped 0.55% to $14,761.30, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Xenetic Biosciences is 4537960, 47.54% below its average volume of 8649680.

Xenetic Biosciences’s last close was $4.07, 30.43% below its 52-week high of $5.85.

The company’s growth estimates for the current quarter is a negative 6.7% and positive 85% for the next.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.

Volatility

Xenetic Biosciences’s last week, last month’s, and last quarter’s current volatility was 8.71%, 1.07%, and 4.79%, respectively.

Xenetic Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.71% (last week), 6.66% (last month), and 4.79% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be overbought (>=80).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $3.52 at 08:34 EST, way below its 52-week high of $5.85 and way higher than its 52-week low of $0.76.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s value is way higher than its 50-day moving average of $2.29 and way higher than its 200-day moving average of $2.32.

More news about Xenetic Biosciences.

3. iFresh (IFMK) – Premarket: 6.56%

NASDAQ Composite ended the session with iFresh falling 1.61% to $1.22 on Wednesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for iFresh is 461451, 14.37% above its average volume of 403455.

iFresh’s last close was $1.35, 68.24% under its 52-week high of $4.25.

iFresh’s Revenue

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 94.26M for the twelve trailing months.

Volatility

iFresh’s last week, last month’s, and last quarter’s current volatility was a negative 0.78%, a negative 1.18%, and a positive 3.19%, respectively.

iFresh’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.55% (last week), 3.67% (last month), and 3.19% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

iFresh’s stock is considered to be oversold (<=20).

iFresh’s Stock Yearly Top and Bottom Value

iFresh’s stock is valued at $1.22 at 08:34 EST, way under its 52-week high of $4.25 and way above its 52-week low of $0.65.

iFresh’s Moving Average

iFresh’s value is below its 50-day moving average of $1.30 and way under its 200-day moving average of $1.41.

More news about iFresh.

4. Upland Software (UPLD) – Premarket: 3.08%

NASDAQ Composite ended the session with Upland Software sliding 1.21% to $35.02 on Wednesday, after two sequential sessions in a row of losses. NASDAQ Composite jumped 0.55% to $14,761.30, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Upland Software is 123802, 44.88% below its average volume of 224587.

Upland Software’s last close was $36.00, 32.08% under its 52-week high of $53.00.

The company’s growth estimates for the current quarter and the next is a negative 30% and a negative 14.5%, respectively.

Upland Software’s Revenue

Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 297.72M for the twelve trailing months.

Volatility

Upland Software’s last week, last month’s, and last quarter’s current volatility was a negative 0.82%, a negative 0.63%, and a positive 1.71%, respectively.

Upland Software’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.03% (last week), 1.38% (last month), and 1.71% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Upland Software’s stock is considered to be overbought (>=80).

Upland Software’s Stock Yearly Top and Bottom Value

Upland Software’s stock is valued at $35.02 at 08:34 EST, way under its 52-week high of $53.00 and higher than its 52-week low of $32.45.

Upland Software’s Moving Average

Upland Software’s worth is way under its 50-day moving average of $39.94 and way under its 200-day moving average of $44.94.

More news about Upland Software.

5. TherapeuticsMD (TXMD) – Premarket: 3.06%

NASDAQ Composite ended the session with TherapeuticsMD falling 2.97% to $0.98 on Wednesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for TherapeuticsMD is 3663460, 39.66% below its average volume of 6070980.

TherapeuticsMD’s last close was $1.00, 63.64% below its 52-week high of $2.75.

The company’s growth estimates for the present quarter and the next is 42.1% and 25%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 62.2%, now sitting on 72.49M for the twelve trailing months.

Volatility

TherapeuticsMD’s last week, last month’s, and last quarter’s current volatility was a negative 0.25%, a negative 0.81%, and a positive 3.47%, respectively.

TherapeuticsMD’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.68% (last week), 3.11% (last month), and 3.47% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.98 at 08:34 EST, way under its 52-week high of $2.75 and above its 52-week low of $0.93.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way below its 50-day moving average of $1.12 and way under its 200-day moving average of $1.34.

More news about TherapeuticsMD.

6. Caesars Entertainment (CZR) – Premarket: 2.55%

NASDAQ Composite ended the session with Caesars Entertainment jumping 0.32% to $86.78 on Wednesday, after four sequential sessions in a row of losses. NASDAQ Composite rose 0.55% to $14,761.30, after two sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Caesars Entertainment is 3848530, 16.28% above its average volume of 3309730.

Caesars Entertainment’s last close was $87.36, 23% below its 52-week high of $113.46.

The company’s growth estimates for the current quarter and the next is 76% and 100.7%, respectively.

Caesars Entertainment’s Revenue

Year-on-year quarterly revenue growth grew by 260.3%, now sitting on 4.69B for the twelve trailing months.

Volatility

Caesars Entertainment’s last week, last month’s, and last quarter’s current volatility was a negative 0.04%, a negative 0.45%, and a positive 2.06%, respectively.

Caesars Entertainment’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.67% (last week), 2.15% (last month), and 2.06% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Caesars Entertainment’s stock is considered to be overbought (>=80).

Caesars Entertainment’s Stock Yearly Top and Bottom Value

Caesars Entertainment’s stock is valued at $86.78 at 08:34 EST, way under its 52-week high of $113.46 and way above its 52-week low of $32.16.

Caesars Entertainment’s Moving Average

Caesars Entertainment’s worth is way under its 50-day moving average of $97.76 and below its 200-day moving average of $93.82.

More news about Caesars Entertainment.

7. DouYu (DOYU) – Premarket: 2.4%

NASDAQ Composite ended the session with DouYu falling 8.54% to $3.75 on Wednesday, following the last session’s upward trend. NASDAQ Composite jumped 0.55% to $14,761.30, after two successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for DouYu is 7557240, 56.59% above its average volume of 4826230.

DouYu’s last close was $4.03, 80.38% under its 52-week high of $20.54.

The company’s growth estimates for the ongoing quarter and the next is a negative 131.2% and a negative 150%, respectively.

DouYu’s Revenue

Year-on-year quarterly revenue growth declined by 5.5%, now sitting on 9.48B for the twelve trailing months.

Volatility

DouYu’s last week, last month’s, and last quarter’s current volatility was a negative 1.91%, a negative 2.96%, and a positive 3.70%, respectively.

DouYu’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.92% (last week), 4.77% (last month), and 3.70% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

DouYu’s stock is considered to be oversold (<=20).

DouYu’s Stock Yearly Top and Bottom Value

DouYu’s stock is valued at $3.75 at 08:34 EST, way under its 52-week high of $20.54 and higher than its 52-week low of $3.69.

DouYu’s Moving Average

DouYu’s value is way below its 50-day moving average of $5.90 and way below its 200-day moving average of $10.03.

More news about DouYu.

8. XP (XP) – Premarket: 2.03%

NASDAQ Composite ended the session with XP jumping 1.46% to $42.30 on Wednesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for XP is 1237970, 8.81% below its average volume of 1357570.

XP’s last close was $41.06, 22.44% below its 52-week high of $52.94.

XP’s Sales

XP’s sales growth is 99.7% for the present quarter and 52.2% for the next. The company’s growth estimates for the current quarter and the next is 38.9% and 31.6%, respectively.

XP’s Revenue

Year-on-year quarterly revenue growth grew by 51.5%, now sitting on 9.04B for the twelve trailing months.

Volatility

XP’s last week, last month’s, and last quarter’s current volatility was a positive 0.45%, a negative 0.41%, and a positive 1.96%, respectively.

XP’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.36% (last week), 2.08% (last month), and 1.96% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

XP’s stock is considered to be overbought (>=80).

XP’s Stock Yearly Top and Bottom Value

XP’s stock is valued at $42.30 at 08:34 EST, way under its 52-week high of $52.94 and way above its 52-week low of $34.53.

XP’s Moving Average

XP’s worth is under its 50-day moving average of $42.60 and above its 200-day moving average of $42.03.

More news about XP.

9. AmerisourceBergen (ABC) – Premarket: 1.97%

NYSE Composite ended the session with AmerisourceBergen rising 0.8% to $123.71 on Wednesday, following the last session’s downward trend. NYSE Composite rose 0.83% to $16,713.46, after two sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for AmerisourceBergen is 875193, 15.35% below its average volume of 1033850.

AmerisourceBergen’s last close was $122.17, 2.93% below its 52-week high of $125.86.

The company’s growth estimates for the ongoing quarter and the next is 9.2% and 21.7%, respectively.

AmerisourceBergen’s Revenue

Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 196.28B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AmerisourceBergen’s stock is considered to be overbought (>=80).

AmerisourceBergen’s Stock Yearly Top and Bottom Value

AmerisourceBergen’s stock is valued at $123.71 at 08:34 EST, below its 52-week high of $125.86 and way above its 52-week low of $92.00.

AmerisourceBergen’s Moving Average

AmerisourceBergen’s worth is above its 50-day moving average of $116.84 and higher than its 200-day moving average of $114.39.

More news about AmerisourceBergen.

10. Empirical Financial Services, LLC d/b/a Empirical Wealth Management (ABC) – Premarket: 1.97%

NYSE Composite ended the session with Empirical Financial Services, LLC d/b/a Empirical Wealth Management jumping 0.8% to $123.71 on Wednesday, following the last session’s downward trend. NYSE Composite jumped 0.83% to $16,713.46, after two successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Empirical Financial Services, LLC d/b/a Empirical Wealth Management is 875193, 15.35% below its average volume of 1033850.

Empirical Financial Services, LLC d/b/a Empirical Wealth Management’s last close was $122.17, 2.93% below its 52-week high of $125.86.

The company’s growth estimates for the current quarter and the next is 9.2% and 21.7%, respectively.

Empirical Financial Services, LLC d/b/a Empirical Wealth Management’s Revenue

Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 196.28B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Empirical Financial Services, LLC d/b/a Empirical Wealth Management’s stock is considered to be overbought (>=80).

Empirical Financial Services, LLC d/b/a Empirical Wealth Management’s Stock Yearly Top and Bottom Value

Empirical Financial Services, LLC d/b/a Empirical Wealth Management’s stock is valued at $123.71 at 08:34 EST, below its 52-week high of $125.86 and way above its 52-week low of $92.00.

Empirical Financial Services, LLC d/b/a Empirical Wealth Management’s Moving Average

Empirical Financial Services, LLC d/b/a Empirical Wealth Management’s value is above its 50-day moving average of $116.84 and above its 200-day moving average of $114.39.

More news about Empirical Financial Services, LLC d/b/a Empirical Wealth Management.

Most Active Premarket Losers Today

1. Akamai Technologies (AKAM) – Premarket: -5.89%

NASDAQ Composite ended the session with Akamai Technologies rising 0.77% to $119.82 on Wednesday, following the last session’s upward trend. NASDAQ Composite jumped 0.55% to $14,761.30, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Akamai Technologies is 1035170, 11.94% below its average volume of 1175540.

Akamai Technologies’s last close was $119.82, 4.07% under its 52-week high of $124.91.

Akamai Technologies’s Revenue

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 3.28B for the twelve trailing months.

Volatility

Akamai Technologies’s last week, last month’s, and last quarter’s current volatility was 0.47%, 0.07%, and 0.67%, respectively.

Akamai Technologies’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.90% (last week), 0.62% (last month), and 0.67% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Akamai Technologies’s stock is considered to be overbought (>=80).

Akamai Technologies’s Stock Yearly Top and Bottom Value

Akamai Technologies’s stock is valued at $119.82 at 08:34 EST, under its 52-week high of $124.91 and way above its 52-week low of $92.64.

Akamai Technologies’s Moving Average

Akamai Technologies’s value is above its 50-day moving average of $117.30 and above its 200-day moving average of $109.34.

Previous days news about Akamai Technologies

Akamai technologies inc Q2 adjusted earnings beat estimates. According to Business Insider on Tuesday, 3 August, "Excluding items, Akamai Technologies Inc reported adjusted earnings of $232.75 million or $1.42 per share for the period."

More news about Akamai Technologies.

2. AMC (AMC) – Premarket: -3.6%

NYSE Composite ended the session with AMC dropping 4.57% to $33.59 on Wednesday while NYSE Composite jumped 0.83% to $16,713.46.

Volume

Today’s last reported volume for AMC is 61202700, 65.03% below its average volume of 175025000.

AMC’s last close was $37.02, 49.02% under its 52-week high of $72.62.

The company’s growth estimates for the ongoing quarter and the next is 82.7% and 93.6%, respectively.

AMC’s Revenue

Year-on-year quarterly revenue growth declined by 84.2%, now sitting on 449.2M for the twelve trailing months.

Volatility

AMC’s last week, last month’s, and last quarter’s current volatility was a positive 1.15%, a negative 1.87%, and a positive 7.86%, respectively.

AMC’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.49% (last week), 6.90% (last month), and 7.86% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AMC’s stock is considered to be overbought (>=80).

AMC’s Stock Yearly Top and Bottom Value

AMC’s stock is valued at $33.59 at 08:34 EST, way under its 52-week high of $72.62 and way higher than its 52-week low of $1.91.

AMC’s Moving Average

AMC’s value is way under its 50-day moving average of $47.42 and way higher than its 200-day moving average of $21.94.

More news about AMC.

3. ImmunoGen (IMGN) – Premarket: -3.54%

NASDAQ Composite ended the session with ImmunoGen sliding 1.22% to $5.65 on Wednesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for ImmunoGen is 1555090, 16.68% below its average volume of 1866350.

ImmunoGen’s last close was $5.61, 48.44% below its 52-week high of $10.88.

ImmunoGen’s Sales

ImmunoGen’s sales growth is 29.7% for the current quarter and 24.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 28.6% and a negative 53.8%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 134.72M for the twelve trailing months.

Volatility

ImmunoGen’s last week, last month’s, and last quarter’s current volatility was a positive 0.32%, a negative 0.77%, and a positive 2.35%, respectively.

ImmunoGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.95% (last week), 1.74% (last month), and 2.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ImmunoGen’s stock is considered to be overbought (>=80).

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $5.65 at 08:34 EST, way below its 52-week high of $10.88 and way above its 52-week low of $3.38.

ImmunoGen’s Moving Average

ImmunoGen’s value is below its 50-day moving average of $6.19 and way under its 200-day moving average of $7.34.

More news about ImmunoGen.

4. Match Group (MTCH) – Premarket: -3.53%

NASDAQ Composite ended the session with Match Group sliding 1.78% to $158.47 on Wednesday while NASDAQ Composite rose 0.55% to $14,761.30.

Volume

Today’s last reported volume for Match Group is 2188580, 7.72% above its average volume of 2031820.

Match Group’s last close was $159.27, 8.82% under its 52-week high of $174.68.

The company’s growth estimates for the present quarter and the next is 59.4% and 26.1%, respectively.

Match Group’s Revenue

Year-on-year quarterly revenue growth grew by 22.6%, now sitting on 2.51B for the twelve trailing months.

Volatility

Match Group’s last week, last month’s, and last quarter’s current volatility was 0.50%, 0.04%, and 1.82%, respectively.

Match Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.62% (last week), 1.48% (last month), and 1.82% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Match Group’s stock is considered to be overbought (>=80).

Match Group’s Stock Yearly Top and Bottom Value

Match Group’s stock is valued at $158.47 at 08:34 EST, under its 52-week high of $174.68 and way higher than its 52-week low of $100.25.

Match Group’s Moving Average

Match Group’s worth is under its 50-day moving average of $158.84 and higher than its 200-day moving average of $150.12.

More news about Match Group.

5. American Tower (AMT) – Premarket: -3.2%

NYSE Composite ended the session with American Tower jumping 0.26% to $284.35 on Wednesday while NYSE Composite jumped 0.83% to $16,713.46.

Volume

Today’s last reported volume for American Tower is 999981, 41.34% below its average volume of 1704710.

American Tower’s last close was $282.80, 2.32% below its 52-week high of $289.51.

American Tower’s Sales

American Tower’s sales growth is 12.4% for the current quarter and 11.9% for the next. The company’s growth estimates for the present quarter and the next is 27% and 19.2%, respectively.

American Tower’s Revenue

Year-on-year quarterly revenue growth grew by 8.3%, now sitting on 8.21B for the twelve trailing months.

Volatility

American Tower’s last week, last month’s, and last quarter’s current volatility was 0.30%, 0.22%, and 0.80%, respectively.

American Tower’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.75% (last week), 0.63% (last month), and 0.80% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

American Tower’s stock is considered to be overbought (>=80).

American Tower’s Stock Yearly Top and Bottom Value

American Tower’s stock is valued at $284.35 at 08:34 EST, below its 52-week high of $289.51 and way higher than its 52-week low of $197.50.

American Tower’s Moving Average

American Tower’s value is above its 50-day moving average of $275.82 and way above its 200-day moving average of $246.87.

More news about American Tower.

6. Vulcan Materials Company (VMC) – Premarket: -2.68%

NYSE Composite ended the session with Vulcan Materials Company jumping 0.71% to $180.85 on Wednesday, after two consecutive sessions in a row of losses. NYSE Composite jumped 0.83% to $16,713.46, after two consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Vulcan Materials Company is 547511, 34.14% below its average volume of 831285.

Vulcan Materials Company’s last close was $179.99, 7.3% below its 52-week high of $194.17.

Vulcan Materials Company’s Sales

Vulcan Materials Company’s sales growth is 4.6% for the ongoing quarter and 7.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 5.6% and 12.2%, respectively.

Vulcan Materials Company’s Revenue

Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 4.88B for the twelve trailing months.

Volatility

Vulcan Materials Company’s last week, last month’s, and last quarter’s current volatility was 0.98%, 0.25%, and 1.13%, respectively.

Vulcan Materials Company’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.59% (last week), 1.09% (last month), and 1.13% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Vulcan Materials Company’s stock is considered to be overbought (>=80).

Vulcan Materials Company’s Stock Yearly Top and Bottom Value

Vulcan Materials Company’s stock is valued at $180.85 at 08:34 EST, under its 52-week high of $194.17 and way above its 52-week low of $114.84.

Vulcan Materials Company’s Moving Average

Vulcan Materials Company’s value is higher than its 50-day moving average of $173.79 and above its 200-day moving average of $171.57.

More news about Vulcan Materials Company.

7. Exact Sciences (EXAS) – Premarket: -2.46%

NASDAQ Composite ended the session with Exact Sciences falling 3.87% to $104.21 on Wednesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for Exact Sciences is 2605570, 75.48% above its average volume of 1484790.

Exact Sciences’s last close was $107.84, 32.41% below its 52-week high of $159.54.

Exact Sciences’s Sales

Exact Sciences’s sales growth is 56.9% for the present quarter and 28.4% for the next. The company’s growth estimates for the present quarter is a negative 27.6% and positive 43.8% for the next.

Exact Sciences’s Revenue

Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 1.55B for the twelve trailing months.

Volatility

Exact Sciences’s last week, last month’s, and last quarter’s current volatility was a negative 0.43%, a negative 0.50%, and a positive 2.19%, respectively.

Exact Sciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.26% (last week), 1.78% (last month), and 2.19% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Exact Sciences’s stock is considered to be overbought (>=80).

Exact Sciences’s Stock Yearly Top and Bottom Value

Exact Sciences’s stock is valued at $104.21 at 08:34 EST, way under its 52-week high of $159.54 and way higher than its 52-week low of $70.75.

Exact Sciences’s Moving Average

Exact Sciences’s worth is way below its 50-day moving average of $120.14 and way under its 200-day moving average of $125.58.

More news about Exact Sciences.

8. ZoomInfo (ZI) – Premarket: -2.21%

NASDAQ Composite ended the session with ZoomInfo jumping 3.14% to $56.50 on Wednesday, following the last session’s downward trend. NASDAQ Composite jumped 0.55% to $14,761.30, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for ZoomInfo is 22764800, 1242.31% above its average volume of 1695930.

ZoomInfo’s last close was $53.75, 15.57% under its 52-week high of $63.66.

ZoomInfo’s Sales

ZoomInfo’s sales growth is 53.8% for the ongoing quarter and 39.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 71.4% and 9.1%, respectively.

ZoomInfo’s Revenue

Year-on-year quarterly revenue growth grew by 50%, now sitting on 527.3M for the twelve trailing months.

Volatility

ZoomInfo’s last week, last month’s, and last quarter’s current volatility was 0.32%, 0.07%, and 2.03%, respectively.

ZoomInfo’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.00% (last week), 1.55% (last month), and 2.03% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ZoomInfo’s stock is considered to be overbought (>=80).

ZoomInfo’s Stock Yearly Top and Bottom Value

ZoomInfo’s stock is valued at $56.50 at 08:34 EST, way below its 52-week high of $63.66 and way above its 52-week low of $30.83.

ZoomInfo’s Moving Average

ZoomInfo’s value is higher than its 50-day moving average of $51.93 and way above its 200-day moving average of $49.45.

More news about ZoomInfo.

9. Arcturus Therapeutics (ARCT) – Premarket: -2.01%

NASDAQ Composite ended the session with Arcturus Therapeutics jumping 68.06% to $58.25 on Wednesday, following the last session’s upward trend. NASDAQ Composite jumped 0.55% to $14,761.30, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Arcturus Therapeutics is 9720840, 1852.13% above its average volume of 497960.

Arcturus Therapeutics’s last close was $31.31, 75.86% under its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is a negative 34.5% for the ongoing quarter and 321.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 289.1% and a negative 129.3%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 1.27%, a negative 0.20%, and a positive 3.35%, respectively.

Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (last week), 3.22% (last month), and 3.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $58.25 at 08:34 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is way above its 50-day moving average of $32.51 and way above its 200-day moving average of $43.28.

More news about Arcturus Therapeutics.

10. Diamondback Energy (FANG) – Premarket: -1.9%

NASDAQ Composite ended the session with Diamondback Energy jumping 4.93% to $80.53 on Wednesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for Diamondback Energy is 4023400, 59.53% above its average volume of 2522050.

Diamondback Energy’s last close was $77.13, 24.77% below its 52-week high of $102.53.

The company’s growth estimates for the current quarter and the next is 1300% and 258.1%, respectively.

Diamondback Energy’s Revenue

Year-on-year quarterly revenue growth grew by 31.3%, now sitting on 2.94B for the twelve trailing months.

Volatility

Diamondback Energy’s last week, last month’s, and last quarter’s current volatility was a positive 0.29%, a negative 0.79%, and a positive 2.50%, respectively.

Diamondback Energy’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.65% (last week), 2.98% (last month), and 2.50% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Diamondback Energy’s stock is considered to be overbought (>=80).

Diamondback Energy’s Stock Yearly Top and Bottom Value

Diamondback Energy’s stock is valued at $80.53 at 08:34 EST, way under its 52-week high of $102.53 and way above its 52-week low of $23.63.

Diamondback Energy’s Moving Average

Diamondback Energy’s value is under its 50-day moving average of $86.57 and above its 200-day moving average of $78.02.

More news about Diamondback Energy.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here